Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov neeg muag khoom ntawm cas 108736-35-2 lanreotide hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas 108736-35-2 lanreotide los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.
| Khoom npe | CAS: 108736-35-2: Lanreotide |
| Kev piav qhia | Lanreotide yog ib tug ntev - ua yeeb yam somatostatin SSTR2 receptor agonist xaiv heev. Cyclic peptide caj qaum txhim kho cov metabolism hauv kev ruaj ntseg, thiab nws tus kheej - sib sau ua ke rau hauv hydrogel ntawm siab concentration rau kev tso tawm. Siv rau hauv kev tshawb fawb mechanism ntawm acromegaly, neuroendocrine qog thiab cov tshuaj hormone secretion disorders. |
| Peptide purity (HPLC, %) | 95%/98%/99% |
| Cov mis mos molecular | C₅₄H₆₉N₁₁O₁₀S₂ (dawb puag) |
| Molecular Luj (Da) | 1096.33 |
| Ntsev daim ntawv | Acetate |
Product Basic Information Table
| Khoom Lub Npe Lus Askiv | Product Abbreviation / Alias | Function Tags (comma-sib cais) | Puv Amino Acid Sequence | Molecular Formula | Exact Mass (Da) | Qhov nruab nrab MW (Da) | N-Terminal Hloov kho | C-Terminal Hloov kho | Qhov ntev (aa) |
| Lanreotide | Lanreotide; BIM-23014; CAS Nr .: 108736-35-2; SSTR2 agonist | Kev xaiv SSTR2 agonist siab, Ntev - ua yeeb yam tso tawm, Acromegaly kawm, Neuroendocrine qog kev tshawb fawb, Hormone secretion suppression, Tus kheej - sib sau ua ke hydrogel | -Naphthylalanine-cysteine-tyrosine-D-tryptophan-lysine-valine-cysteine-threoninamide (cyclized ntawm Cys2-Cys7 disulfide choj) | C₅₄H₆₉N₁₁O₁₀S₂ (dawb puag) | 1095.46 | 1096.33 | Dawb amine, nrog -Nal unnatural amino acid | Amidation | 8 |
Physicochemical Solubility & Cia Parameters
| Khoom Code | Qhov tshwm sim | Ntev - Lub Sij Hawm Cia Cov Cai | Luv luv -Lub Sijhawm Cia Cia | Kua Stability | Khoom hmoov ruaj khov |
| PEB-LAN001 | hmoov dawb | Khaws ntawm -20℃, nruj me ntsis tiv thaiv los ntawm lub teeb, kaw thiab qhuav, aliquoted; zam rov qab khov-thaw cycles. nruj me ntsis txwv tsis pub txo cov neeg ua haujlwm | Khoom hmoov ruaj khov rau 2 xyoos ntawm 2-8℃kaw thiab qhuav; npaj cov kev daws teeb meem qis dua tshiab ua ntej siv | ruaj khov rau 72 h ntawm 4 degree; ruaj khov rau 1 lub hlis ntawm -20℃hauv aliquots. Cov dej zoo solubility ntawm tsawg concentration; tus kheej- sib sau ua ke rau hauv hydrogel ntawm siab concentration. Disulfide choj yog rhiab heev rau cov muaj zog txo cov neeg ua haujlwm thiab ua rau cleavage. Lub teeb-sensitive thiab yooj yim degraded, nruj lub teeb tiv thaiv yuav tsum tau | ruaj khov rau 3 xyoos ntawm -20℃nyob rau hauv qhuav & tsaus ntuj |
Functional Description
| Khoom Code | Frontend Short Summary (rau cov npe tshawb nrhiav) | Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg | Cov cheeb tsam tshawb fawb (comma- cais) | Lub Hom Phiaj / Txoj Kev |
| PEB-LAN001 | Kev xaiv SSTR2 agonist siab heev nrog tus kheej - sib sau ua ke hydrogel ntev - ua yeeb yam tsis tu ncua, inhibits cov tshuaj hormone secretion thiab qog proliferation | Lanreotide yog thib ob - tiam somatostatin analog nrog yim -amino acid cyclic nraub qaum. -Naphthylalanine hloov kho txhim kho receptor affinity thiab metabolic stability, thiab C-terminal amidation txuas ntxiv ib nrab - lub neej. Nws khi nrog kev xaiv siab rau somatostatin SSTR2 receptor, inhibits adenylate cyclase kom txo cov qib cAMP, muaj zog inhibits secretion ntawm ntau yam tshuaj hormones xws li kev loj hlob hormone, insulin thiab glucagon, thiab ib txhij inhibits qog cell proliferation thiab constricts qog cov hlab ntsha. Nws cov qauv molecular tshwj xeeb ua rau nws tus kheej- sib sau ua ke rau hauv nanofiber hydrogel hauv siab -concentration aqueous tov, nrog qeeb tso tawm tom qab txhaj tshuaj subcutaneous thiab ib nrab- lub neej ntawm ob peb hnub rau ntev - kev kho mob. Nws ua haujlwm raws li cov cuab yeej tseem ceeb peptide rau acromegaly, qog nqaij hlav neuroendocrine thiab cov tshuaj hormone secretion disorder mechanism kev tshawb fawb, nrog rau ntev - ua yeeb yam tshuaj somatostatin. | Kev tshawb fawb Acromegaly, Neuroendocrine qog kev tshawb fawb, Hormone secretion regulation research, Self-assembling hydrogel study, Long-acting peptide drug development, qog proliferation inhibition research | Somatostatin Receptor 2 (SSTR2); cAMP/PKA teeb liab txoj kev; Hormone secretion tswj txoj hauv kev; Tus kheej- sib dhos nanofiber tsim mechanism |
Cim npe nrov: CAS 108736-35-2 lanreotide, Tuam Tshoj cas 108736-35-2 lanreotide manufacturers, lwm tus, Hoobkas
